HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuya Atsumi Selected Research

Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)

1/2022Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
1/2022Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
10/2021Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
5/2021[Neurological Manifestations in Antiphospholipid Syndrome].
12/2019Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
12/2019The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
3/2019The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
1/2019The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
1/2019Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation.
1/2019Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuya Atsumi Research Topics

Disease

59Rheumatoid Arthritis
09/2022 - 06/2004
56Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2022 - 02/2002
31Type 2 Diabetes Mellitus (MODY)
05/2022 - 01/2015
30Thrombosis (Thrombus)
10/2021 - 06/2002
25Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 01/2004
20Autoimmune Diseases (Autoimmune Disease)
05/2021 - 01/2004
14Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03/2022 - 06/2012
13Vasculitis (Vasculitides)
04/2022 - 01/2016
12Infections
04/2022 - 01/2009
10Hypoglycemia (Reactive Hypoglycemia)
05/2022 - 01/2016
9Atherosclerosis
06/2022 - 04/2003
8Thrombocytopenia (Thrombopenia)
01/2022 - 10/2003
8Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 10/2012
8Inflammation (Inflammations)
01/2021 - 01/2004
7Body Weight (Weight, Body)
03/2021 - 03/2017
6Dermatomyositis (Dermatopolymyositis)
11/2022 - 01/2015
6Neoplasms (Cancer)
04/2022 - 01/2016
6Hypertension (High Blood Pressure)
10/2021 - 06/2011
6Hyperglycemia
08/2021 - 01/2015
5Fibrosis (Cirrhosis)
01/2022 - 01/2013
5Pulmonary Arterial Hypertension
01/2020 - 11/2007
5Arthritis (Polyarthritis)
01/2020 - 02/2015
5Systemic Scleroderma (Systemic Sclerosis)
11/2019 - 06/2009
4Polymyositis
11/2022 - 01/2015
4Insulin Resistance
09/2021 - 10/2015
4Osteoporosis
07/2021 - 11/2016
4Fatty Liver
07/2021 - 03/2017
4Pituitary Neoplasms (Pituitary Adenoma)
04/2021 - 01/2019
4Adenoma (Adenomas)
02/2021 - 11/2018
4Disease Progression
11/2020 - 01/2019
4Hemorrhage
01/2020 - 09/2017
4Microscopic Polyangiitis
01/2019 - 05/2014
3Atherosclerotic Plaque (Atheroma)
06/2022 - 01/2018
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2022 - 05/2013
3Diabetes Mellitus
08/2021 - 05/2021
3Bone Resorption
07/2021 - 11/2016
3Fever (Fevers)
04/2021 - 01/2019
3Obesity
02/2021 - 12/2014
3Glomerulonephritis
01/2021 - 03/2019

Drug/Important Bio-Agent (IBA)

41Antiphospholipid AntibodiesIBA
01/2022 - 07/2002
30Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2015
25AntibodiesIBA
02/2022 - 02/2002
18AutoantibodiesIBA
01/2019 - 12/2002
17Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2022 - 06/2012
14Methotrexate (Mexate)FDA LinkGeneric
03/2022 - 12/2010
14tocilizumab (atlizumab)FDA Link
05/2020 - 01/2009
14Biological ProductsIBA
01/2020 - 01/2009
14Immunoglobulin G (IgG)IBA
01/2019 - 07/2002
13GlucocorticoidsIBA
11/2022 - 05/2005
13Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2007
13Insulin (Novolin)FDA Link
05/2022 - 10/2015
12Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
07/2020 - 02/2002
9PhosphatidylserinesIBA
07/2018 - 02/2002
8Dipeptidyl-Peptidase IV InhibitorsIBA
01/2022 - 01/2016
8Prothrombin (Factor II)IBA
07/2018 - 02/2002
8beta 2-Glycoprotein I (Apolipoprotein H)IBA
01/2016 - 07/2002
7Antirheumatic Agents (DMARD)IBA
02/2022 - 07/2011
7Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2016
7Anticardiolipin AntibodiesIBA
12/2019 - 12/2002
7Glycoproteins (Glycoprotein)IBA
12/2019 - 12/2002
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 09/2005
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2022 - 04/2012
6SodiumIBA
08/2021 - 06/2016
6Phospholipids (Phosphatides)FDA LinkGeneric
05/2021 - 01/2004
6Infliximab (Remicade)FDA Link
07/2020 - 07/2007
6DNA (Deoxyribonucleic Acid)IBA
03/2019 - 10/2011
5GLPG0634IBA
04/2022 - 01/2021
5SteroidsIBA
04/2022 - 08/2016
5Etanercept (Enbrel)FDA Link
03/2022 - 12/2010
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2021 - 05/2013
5ipragliflozinIBA
11/2019 - 06/2016
5EnzymesIBA
12/2018 - 01/2013
5Peroxidase (Myeloperoxidase)IBA
10/2018 - 06/2012
5Immunoglobulin M (IgM)IBA
01/2016 - 02/2005
5AntigensIBA
06/2010 - 07/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022 - 06/2012
4Abatacept (Orencia)FDA Link
04/2022 - 06/2016
4Prednisolone (Predate)FDA LinkGeneric
03/2022 - 12/2010
4Biomarkers (Surrogate Marker)IBA
02/2022 - 12/2015
4LiraglutideFDA Link
01/2022 - 01/2015
4Tacrolimus (Prograf)FDA LinkGeneric
01/2020 - 01/2015
4Tumor Necrosis Factor InhibitorsIBA
08/2018 - 07/2011
4AutoantigensIBA
04/2015 - 04/2003
3LipidsIBA
06/2022 - 10/2017
3Rituximab (Mabthera)FDA Link
03/2022 - 07/2015
3baricitinibIBA
02/2022 - 07/2018
3IncretinsIBA
01/2022 - 01/2016
3Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 10/2019
3Monoclonal AntibodiesIBA
01/2022 - 01/2009
3Phosphates (Orthophosphate)IBA
11/2021 - 09/2017
3Pharmaceutical PreparationsIBA
11/2021 - 11/2012
3Diphosphonates (Bisphosphonates)IBA
07/2021 - 11/2016
3Triglycerides (Triacylglycerol)IBA
07/2021 - 01/2018
3dapagliflozinIBA
07/2021 - 01/2017
3Hemoglobins (Hemoglobin)IBA
05/2021 - 01/2017
3Adrenocorticotropic Hormone (ACTH)FDA Link
04/2021 - 10/2019
3Hypoglycemic Agents (Hypoglycemics)IBA
03/2021 - 09/2018
3Transcription Factors (Transcription Factor)IBA
02/2021 - 06/2010

Therapy/Procedure

39Therapeutics
04/2022 - 05/2005
11Glycemic Control
05/2022 - 01/2018